Mellaril (thioridazine HCL)

Health professionals are notified of important labeling changes for all dosage forms of Mellaril. The new changes include a boxed warning, a change in the indication, contraindications with certain other drugs, and new recommendations for baseline monitoring and overdosage treatment.

[July 7, 2000 - Letter - Novartis Pharmaceuticals Corp.]